Adient (ADNT)
(Delayed Data from NYSE)
$22.33 USD
+0.17 (0.77%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $22.33 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.33 USD
+0.17 (0.77%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $22.33 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth D Momentum B VGM
Zacks News
Will Adient Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Adient.
Zacks.com featured highlights include: Atlas Air Worldwide, AmerisourceBergen, Murphy USA, Sally Beauty and Adient PLC
by Zacks Equity Research
Zacks.com featured highlights include: Atlas Air Worldwide, AmerisourceBergen, Murphy USA, Sally Beauty and Adient PLC
Moving Average Crossover Alert: Adient
by Zacks Equity Research
Adient plc (ADNT) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
5 Stocks That Look Appealing Post Broker Rating Upgrades
by Maharathi Basu
Brokers have a lot more information on a company, at their disposal, and its prospects than individual investors.
ADNT vs. RACE: Which Stock Is the Better Value Option?
by Zacks Equity Research
ADNT vs. RACE: Which Stock Is the Better Value Option?
Adient (ADNT) Tops Q1 Earnings & Sales Estimates, Tweaks View
by Zacks Equity Research
For 2020, Adient (ADNT) projects adjusted EBITDA at $870-$910 million, up from the prior guidance of $820-$860 million.
Adient (ADNT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 209.68% and 2.51%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Adient (ADNT) This Earnings Season?
by Zacks Equity Research
Adient (ADNT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Adient (ADNT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Adient (ADNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Truth About Market Timing - January 22, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Can Adient (ADNT) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Adient (ADNT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Truth About Market Timing - December 27, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Truth About Market Timing - December 09, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
The Market Timing Secrets No One Talks About - November 18, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Adient (ADNT) Rallies 46% YTD: Can the Bull Run Continue?
by Zacks Equity Research
While Adient's (ADNT) restructuring efforts bode well for the long term, we are skeptical of the company's ability to navigate choppy waters amid macro-economic headwinds.
New Strong Sell Stocks for November 13th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Adient (ADNT) Q4 Earnings Top Estimates, Down Y/Y
by Zacks Equity Research
Adient (ADNT) delivers a dismal fiscal Q4 performance due to weaker contribution across all segments.
Adient (ADNT) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 152.00% and -1.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Adient (ADNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
When Does Market Timing Actually Work? - October 30, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Adient Aided by Turnaround Plans Amid Industry Headwinds
by Zacks Equity Research
While measures to improve Adient's (ADNT) operating and financial performance are paying off, U.S.-Sino trade tensions remain a concern.
Yes, You Can Time the Market. Find out How - October 01, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Timing the Market, Is it Possible? - September 11, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Adient (ADNT) Down 13.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
How to Time the Markets Like an Investing Pro - August 19, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?